Shire Price Target Lowered to GBX 36 at Investec (SHP)
Stock analysts at Investec cut their target price on shares of Shire (LON:SHP) from GBX 38 ($0.63) to GBX 36 ($0.59) in a report issued on Thursday, AmericanBankingNews.com reports. The firm currently has a “buy” rating on the stock. Investec’s price objective indicates a potential downside of 98.80% from the company’s current price.
Other equities research analysts have also recently issued reports about the stock. Analysts at Berenberg Bank raised their price target on shares of Shire from GBX 2,350 ($38.73) to GBX 2,900 ($47.79) in a research note to investors on Thursday. They now have a “hold” rating on the stock. Separately, analysts at Credit Suisse reiterated a “neutral” rating on shares of Shire in a research note to investors on Wednesday. They now have a GBX 2,900 ($47.79) price target on the stock. Finally, analysts at Deutsche Bank reiterated a “buy” rating on shares of Shire in a research note to investors on Wednesday. They now have a GBX 3,850 ($63.45) price target on the stock. One analyst has rated the stock with a sell rating, nine have assigned a hold rating, fifteen have assigned a buy rating and one has issued a strong buy rating to the company’s stock. The stock presently has an average rating of “Buy” and an average price target of GBX 2,560.63 ($42.20).
Shire plc (LON:SHP) is a specialty biopharmaceutical company that focuses on meeting the needs of the specialist physician.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.